NEPHROCARE

Nephro Care India Share Price

₹251.00 +25.1 (11.11%)

21 Nov, 2024 14:06

SIP TrendupStart SIP in NEPHROCARE

Start SIP

Performance

  • Low
  • ₹217
  • High
  • ₹217
  • 52 Week Low
  • ₹171
  • 52 Week High
  • ₹379
  • Open Price₹217
  • Previous Close₹221
  • Volume1,200

Investment Returns

  • Over 1 Month + 2.05%
  • Over 3 Month -9.03%
  • Over 6 Month + 178.89%
  • Over 1 Year + 178.89%
SIP Lightning

Smart Investing Starts Here Start SIP with Nephro Care India for Steady Growth!

Invest Now

Nephro Care India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 414
  • P/B Ratio
  • 27.5
  • Average True Range
  • 8.4
  • EPS
  • 2.62
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.49
  • RSI
  • 36.03
  • MFI
  • 46.19

Nephro Care India Financials

Nephro Care India Technicals

EMA & SMA

Current Price
₹251.00
+ 25.1 (11.11%)
pointer
  • stock-down_img
  • Bullish Moving Average 11
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹239.57
  • 50 Day
  • ₹246.24
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

221.4 Pivot Speed
  • R3 221.40
  • R2 221.40
  • R1 221.40
  • S1 221.40
  • S2 221.40
  • S3 221.40

What's your outlook on Nephro Care India?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Nephro Care India Ltd has an operating revenue of Rs. 49.57 Cr. on a trailing 12-month basis. An annual revenue growth of 61% is outstanding, Pre-tax margin of 23% is great, ROE of 29% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 30 indicates it belongs to a strong industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nephro Care India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-08 Quarterly Results & Others To consider other business matters
2024-08-20 Audited Results To consider and approve the financial results for the period ended March 31, 2024 and other business matters
2024-07-19 Others To consider other business matters

Nephro Care India F&O

Nephro Care India Shareholding Pattern

61.38%
3.92%
0.03%
24.6%
10.07%

About Nephro Care India

  • NSE Symbol
  • NEPHROCARE
  • BSE Symbol
  • Managing Director
  • Dr. Pratim Sengupta
  • ISIN
  • INE0SUN01013

Similar Stocks to Nephro Care India

Nephro Care India FAQs

Nephro Care India share price is ₹251 As on 21 November, 2024 | 13:52

The Market Cap of Nephro Care India is ₹413.8 Cr As on 21 November, 2024 | 13:52

The P/E ratio of Nephro Care India is As on 21 November, 2024 | 13:52

The PB ratio of Nephro Care India is 27.5 As on 21 November, 2024 | 13:52

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23